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Objectives: This study reported the clinical outcomes of our experi-
ence in the use of fenestrated endovascular grafts (FEVAR) for the treat-
ment of juxtarenal and suprarenal aortic aneurysms in patients at high risk
for open repair over a 9-year period.
Methods: A retrospective cohort study was conducted on a consecu-
tive series of patients who had undergone FEVAR for juxtarenal or suprarenal
aneurysms with fenestrated grafts between 2004 and 2013 at two university
hospitals. Preoperative risk factors and preoperative aortic anatomy were
retrieved from patient medical imaging and records. Evaluated outcomes
included procedure details, postoperative complications, length of hospital
stay and follow-up, mortality, endoleak, and secondary interventions.
Results: Over the study period, 59 patients were treated with FEVAR.
The mean age was 75 years, 84.7% were male. Most of the treated aneurysms
were juxtarenal (77.9%), with a median aneurysm diameter of 6 cm. Initial
technical success was achieved in 58 of 59 patients (98%), with one open con-
version. The 30-day mortality rate was 8.4%. Acute renal failure represented
the most common postoperative morbidity (16.9%), followed by myocardial
infarction (10%). The median hospital length of stay was 6 days. The median
postoperative follow-up including imaging with computed tomography
angiogram or ultrasound imaging was 11.5 months. The overall mortality
rate in the series was 15%, and myocardial infarction was the most common
cause of death (60%). Endoleaks were identiﬁed in 15 patients (25.4%) dur-
ing follow-up imaging. Secondary intervention was performed in ﬁve patients
(8.4%), with four of them for endoleak treatment.
Conclusions: The short-term and intermediate-term results of
FEVAR for juxtarenal and suprarenal abdominal aortic aneurysm repair
were acceptable in this population at high-risk for open repair.
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Objectives: This study was conducted to demonstrate that in situ
fenestration of stent grafts will soon allow patients presenting with most
life-threatening aortic pathologies to be amenable to emergency “off the
shelf” percutaneous treatments.
Methods: Three types of thoracic stent graftsdCook Zenith TX2
(stainless steel stents and multiﬁlament woven fabric), Medtronic Valiant
(nitinol stents and monoﬁlament woven fabric), and Vascutek Anaconda
(nitinol stents and multiﬁlament woven fabric)dwere subjected to laser
fenestration in vitro in a physiologic saline solution, followed by balloon an-
gioplasty of an 8-mm, 10-mm, or 12-mm in diameter noncompliant balloon.
The fenestrations were observed nondestructively (gross observations and
light microscopy) and destructively (scanning electron microscopy).1398Results: The creation of fenestrations was feasible in each of the three
devices. Each device demonstrated varying degrees of fraying or tearing, or
both. The monoﬁlament twill weave (Medtronic Valiant) tore in two direc-
tions (warp and weft), whereas the multiﬁlament weave (Anaconda Vascu-
tek and Zenith TX2 Cook) fenestrations showed more fraying. The size and
directions of tearing were more predictable with the 8-mm-diameter
balloon, whereas the results obtained with the 10-mm-diameter and 12-
mm-diameter balloons were more unpredictable. The fenestrations were
free of melting of the yarns and blackening of the ﬁlaments.
Conclusions: The in situ fenestration is feasible, but the observed
damage caused to the fabric constructions must be carefully considered.
This procedure must currently be limited to urgent and emergency life-
threatening cases. It is preferable not to use balloons of >8 mm in diameter.
Further study is required to evaluate the effects of balloon-expandable or
self-expanding covered stents that would need to be placed into the adjacent
vessels through these fenestrations in vivo.
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Objectives: This study reviewed local bench studies on in situ fenes-
tration of aortic endografts to identify clinical applicability of lessons
learned, reviewed early local experience with clinical cases of carotid and
subclavian in situ fenestration, and identiﬁed of risk factors for failure.
Methods: The results of local experimental bench studies were used
as guidance for clinical cases of in situ fenestration of the aortic arch; for
example, conventional balloons for Medtronic endografts but cutting bal-
loons for Cook endografts. We then reviewed our institution’s clinical at-
tempts at in situ fenestration of the aortic arch, with a particular focus on
failure mechanisms.
Results: Between June 2011 and November 2013, we had planned
nine left subclavian artery fenestrations and one left common carotid artery
fenestration. Technical success was achieved in six patients. Two of the
remaining four patients did not require revascularization, one received a
chimney instead of attempt at fenestration, and the attempt in one was
unsuccessful, requiring carotid-axillary bypass. There were no fenestration-
related complications, but overall surgical complications included 1 parapare-
sis that resolved with spinal drain, 1 elevated troponin, 1 transient creatinine
elevation, 1 gout, and 1 death from an esophageal ﬁstula that eroded through
the distal anastomosis of a previous open repair of a type B aortic dissection
that was remote from the thoracic endovascular aortic repair site.
Conclusions: Bench studies suggest (1) that conventional angioplasty
balloons cannot create an adequately sized fenestration with the Cook
Zenith fabric and adjunctive methods are needed, (2) caution should be
used with the Medtronic Talent, and (3) conventional radiofrequency
wire cannot penetrate polytetraﬂuoroethylene. Early clinical results suggest
feasibility and ease of use in favorable anatomy but difﬁculties with the type
III arch. The ability to alternate from “barrel view” and “open-arch view” is
an important imaging guide.
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